Free Newsletter
Grassley: Whistleblowers, call me
Scientists, Senator Charles Grassley (R-IA) wants you. Yesterday on the Senate floor, Grassley rehashed some old pharma company-intimidating-scientist cases--including Merck on Vioxx and GlaxoSmithKline on Avandia. This is old news to anyone in pharma and most everyone else who reads the news daily. But it doesn't matter, because it was just bait.
Grassley wants any would-be whistleblowers to call his office. He also solicited contact from scientists whose employers bully them into suppressing data. Anonymous tips are OK, too, he said. Just call. Even better, fax secret documents to 202-228-2131. Any bets on how many calls he'll get?
- see Grassley's floor statement for more
Related Articles:
FDA's showdown with Grassley to delay nomination. Report
Grassley investigates Medicaid drug claims. Report
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline


SHARE
WITH: